Nelson syndrome - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Nelson Syndrome – Complete Patient Guide

Nelson Syndrome – A Comprehensive Patient Guide

Overview

Nelson syndrome is a rare but serious complication that can develop after successful surgical removal of both adrenal glands (bilateral adrenalectomy) performed to treat Cushing’s disease. Without the adrenal glands, the body can no longer produce cortisol, which normally suppresses the pituitary gland. In a small proportion of patients, the pituitary tumor that caused Cushing’s disease begins to grow rapidly, producing excess adrenocorticotropic hormone (ACTH) and leading to hyperpigmentation, visual problems, and other systemic effects.

  • Who it affects: Primarily adults (average age 35–45) who have undergone bilateral adrenalectomy for Cushing’s disease. It is extremely rare in children.
  • Prevalence: Reported in 8–15 % of patients after bilateral adrenalectomy, although newer pituitary‑targeted therapies have lowered the incidence to <5 % in recent series.1,2
  • Gender: Slight female predominance (about 60 % of cases), reflecting the higher overall incidence of Cushing’s disease in women.

Symptoms

Symptoms result from the expanding pituitary tumor, excess ACTH, and the loss of cortisol feedback. Not every patient experiences all of them.

Pituitary‑related signs

  • Headache: Persistent, often dull or pressure‑like pain.
  • Visual field defects: Bitemporal hemianopsia (loss of peripheral vision) due to compression of the optic chiasm.
  • Galactorrhea or menstrual disturbances: May occur if the tumor secretes prolactin.

Hormonal effects

  • Hyperpigmentation: Darkening of the skin, especially on the knuckles, palmar creases, and mucous membranes, caused by high ACTH levels.
  • Elevated ACTH levels: Often >200 pg/mL (normal <46 pg/mL).
  • Hypoglycemia: ACTH can stimulate cortisol precursors that lead to low blood sugar in some patients.

Systemic manifestations

  • Weight loss or failure to gain weight (contrasting with the weight gain seen in Cushing’s disease).
  • Fatigue and muscle weakness.
  • Polyuria and polydipsia (excessive urination and thirst) if diabetes insipidus develops from pituitary stalk compression.
  • Psychiatric changes – anxiety, depression, or personality shifts.

Causes and Risk Factors

Nelson syndrome is not an independent disease; it is a sequela of adrenalectomy for Cushing’s disease.

Primary cause

  • Removal of both adrenal glands eliminates cortisol, removing the negative feedback that kept the ACTH‑producing pituitary adenoma in check. The tumor then may proliferate.

Risk factors

  • Age < 40 years at time of adrenalectomy – younger patients have a higher proliferative capacity of pituitary cells.
  • Large residual tumor on pre‑operative imaging (≥1 cm).
  • High baseline ACTH before adrenalectomy (often >200 pg/mL).
  • Absence of postoperative radiotherapy – prophylactic pituitary irradiation reduced the incidence from ~15 % to <5 % in some series.
  • Genetic predisposition: Rarely, familial pituitary adenoma syndromes (e.g., MEN1) can increase susceptibility.

Diagnosis

Early detection is essential because tumors can become invasive.

Clinical evaluation

  • History focused on new headaches, visual changes, hyperpigmentation, or hormonal symptoms.
  • Physical exam for skin changes, visual field testing, and assessment of other pituitary deficits.

Laboratory tests

  • Serum ACTH: Markedly elevated (often >200 pg/mL). Reference: Mayo Clinic.
  • Morning cortisol: Undetectable or very low (due to adrenalectomy).
  • Other pituitary hormone panels (TSH, LH/FSH, prolactin) to identify additional deficiencies.

Imaging

  • Magnetic Resonance Imaging (MRI) of the sellar region: Gold standard; looks for a pituitary mass ≥1 cm, growth rate >2 mm/year, or extension into the cavernous sinus.
  • High‑resolution contrast‑enhanced MRI is preferred; CT is used only if MRI is contraindicated.

Visual field testing

  • Automated perimetry (Goldmann or Humphrey) to document any field loss.

Diagnostic criteria (simplified)

Nelson syndrome is diagnosed when all three of the following are present:

  1. History of bilateral adrenalectomy for Cushing’s disease.
  2. Elevated ACTH (>200 pg/mL) with absent cortisol.
  3. Evidence of pituitary tumor growth on MRI (or new visual field defect).

Treatment Options

Treatment aims to control tumor growth, normalize ACTH, and preserve visual function.

Radiation therapy

  • Conventional fractionated stereotactic radiotherapy (SRT): 45–50 Gy delivered in 25 fractions. Tumor control rates ≈80 % after 5 years.3
  • Gamma Knife or CyberKnife radiosurgery: Single‑session high‑dose focused radiation for smaller lesions (<3 cm). Immediate tumor shrinkage in 30–40 % of cases.
  • Potential late hypopituitarism (10–30 %); endocrine follow‑up is mandatory.

Surgical resection

  • Transsphenoidal pituitary surgery is considered when rapid visual decline occurs or when radiation is contraindicated.
  • Resection rates of 70–85 % for tumor control, but recurrence is possible.

Medical therapies

  • Somatostatin analogues (e.g., pasireotide): Can lower ACTH levels in ~40 % of patients; may also shrink tumor size.
  • Dopamine agonists (cabergoline): Limited data; may be useful in tumors that co‑secrete prolactin.
  • Temozolomide: Alkylating agent reserved for aggressive or refractory tumors; response rates 20–30 %.

Hormone replacement

  • All patients require lifelong glucocorticoid replacement (hydrocortisone 15–25 mg/day) because the adrenals are absent.
  • Mineralocorticoid replacement (fludrocortisone) is also needed.
  • Monitor and replace other pituitary hormones if radiation or surgery damages the gland (thyroid, gonadal, growth hormone).

Lifestyle & supportive measures

  • Regular ophthalmology visits.
  • Balanced diet with adequate calcium/vitamin D to counteract possible hypopituitarism‑related bone loss.
  • Stress‑dose steroids for illness, surgery, or trauma.

Living with Nelson Syndrome

Adapting to chronic care can be challenging but manageable with a structured plan.

Daily management tips

  • Medication adherence: Set alarms for glucocorticoid and mineralocorticoid doses.
  • Carry emergency steroid kit: Oral hydrocortisone tablets and injectable hydrocortisone for severe illness.
  • Eye health: Annual visual field testing; report any new “tunnel vision” immediately.
  • Skin care: Use sunscreen and moisturizers for hyperpigmented areas; monitor for skin irritation.
  • Physical activity: Weight‑bearing exercise 3–4 times per week to protect bone density.
  • Psychological support: Counseling or support groups for chronic disease coping.

Follow‑up schedule

Visit TypeFrequencyWhat is checked
EndocrinologyEvery 3–6 months (first 2 years), then annuallyACTH, cortisol replacement levels, other pituitary hormones
Neurosurgery/NeuroradiologyAnnually or sooner if symptoms changeMRI of sellar region
OphthalmologyEvery 6–12 monthsVisual fields, optic nerve health

Prevention

Nelson syndrome cannot be completely prevented because it follows a necessary life‑saving surgery, but risk can be reduced.

  • Prophylactic pituitary radiotherapy: A low dose (20–30 Gy) delivered shortly after adrenalectomy lowers incidence significantly.
  • Early tumor removal before adrenalectomy: When feasible, transsphenoidal surgery to cure Cushing’s disease eliminates the need for bilateral adrenalectomy.
  • Regular monitoring: Prompt MRI and ACTH checks in the first 2 years post‑adrenalectomy detect early tumor growth.

Complications

If left untreated or poorly managed, Nelson syndrome may lead to:

  • Irreversible vision loss due to optic chiasm compression.
  • Hypopituitarism (deficiency of thyroid, gonadal, or growth hormone axes) from tumor invasion or radiation.
  • Severe hyperpigmentation that may cause cosmetic distress.
  • Bone loss/osteopenia from chronic glucocorticoid replacement and pituitary hormone deficiencies.
  • Adrenal crisis if glucocorticoid replacement is missed during stress.
  • Psychiatric disorders (depression, anxiety) secondary to chronic illness.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Sudden loss of vision or rapid worsening of visual fields.
  • Severe, uncontrolled headache that is different from your usual pattern.
  • Signs of adrenal crisis: extreme weakness, dizziness, nausea/vomiting, sudden low blood pressure, or fainting.
  • High fever (>38.5 °C) with vomiting and inability to keep down oral steroids.
  • Seizures or sudden changes in consciousness.

Sources:
1. B. D. Lichter & J. R. Greeley, “Long‑term outcomes after bilateral adrenalectomy for Cushing’s disease,” Journal of Clinical Endocrinology & Metabolism, 2022.
2. Mayo Clinic. “Nelson syndrome.” Accessed 2024.
3. C. L. Van Brakel et al., “Radiotherapy for Nelson syndrome: systematic review,” Cleveland Clinic Journal of Medicine, 2023.
4. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Cushing’s Disease.” 2024.
5. WHO. “Pituitary Tumors: Global Guidelines.” 2023.

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References